"Immunosuppressive Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.
| Descriptor ID |
D007166
|
| MeSH Number(s) |
D27.505.696.477.656
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Immunosuppressive Agents".
Below are MeSH descriptors whose meaning is more specific than "Immunosuppressive Agents".
This graph shows the total number of publications written about "Immunosuppressive Agents" by people in this website by year, and whether "Immunosuppressive Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 52 | 18 | 70 |
| 1992 | 34 | 29 | 63 |
| 1993 | 56 | 32 | 88 |
| 1994 | 39 | 31 | 70 |
| 1995 | 69 | 44 | 113 |
| 1996 | 150 | 102 | 252 |
| 1997 | 138 | 87 | 225 |
| 1998 | 160 | 104 | 264 |
| 1999 | 146 | 79 | 225 |
| 2000 | 151 | 133 | 284 |
| 2001 | 181 | 132 | 313 |
| 2002 | 568 | 423 | 991 |
| 2003 | 653 | 481 | 1134 |
| 2004 | 725 | 566 | 1291 |
| 2005 | 854 | 644 | 1498 |
| 2006 | 824 | 608 | 1432 |
| 2007 | 802 | 692 | 1494 |
| 2008 | 871 | 732 | 1603 |
| 2009 | 902 | 832 | 1734 |
| 2010 | 961 | 850 | 1811 |
| 2011 | 967 | 911 | 1878 |
| 2012 | 976 | 896 | 1872 |
| 2013 | 1043 | 905 | 1948 |
| 2014 | 1116 | 933 | 2049 |
| 2015 | 1013 | 897 | 1910 |
| 2016 | 978 | 902 | 1880 |
| 2017 | 995 | 795 | 1790 |
| 2018 | 844 | 732 | 1576 |
| 2019 | 315 | 284 | 599 |
| 2020 | 213 | 199 | 412 |
| 2021 | 18 | 18 | 36 |
To return to the timeline, click here.
Below are the most recent publications written about "Immunosuppressive Agents" by people in Profiles.
-
Immunosuppression in kidney transplant recipients with COVID-19 infection - where do we stand and where are we heading? Ren Fail. 2021 Dec; 43(1):273-280.
-
Effect of Calcineurin Inhibitors and Mammalian Target of Rapamycin Inhibitors on the Course of COVID-19 in Kidney Transplant Recipients. Ann Transplant. 2021 Mar 12; 26:e929279.
-
Humoral response to COVID-19 infection in immunosuppressed patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2021 03 01; 33(3):443-447.
-
Organ Transplantation in the Era of the COVID-19 Global Pandemic. Isr Med Assoc J. 2021 Mar; 23(3):145-146.
-
A 64-Year-Old Man With Multifocal Infiltrates. Chest. 2021 03; 159(3):e151-e154.
-
COVID-19 in Chronic Liver Disease and Liver Transplantation: A Clinical Review. J Clin Gastroenterol. 2021 03 01; 55(3):187-194.
-
SARS-CoV-2 Serologic Immune Response in Exogenously Immunosuppressed Patients. J Appl Lab Med. 2021 03 01; 6(2):486-490.
-
SARS-CoV-2 infection and recurrence of anti-glomerular basement disease: a case report. BMC Nephrol. 2021 02 27; 22(1):75.
-
Simultaneous Inhibition of SARS-CoV-2 Entry Pathways by Cyclosporine. ACS Chem Neurosci. 2021 03 03; 12(5):930-944.
-
Anti-BCMA CAR T administration in a relapsed and refractory multiple myeloma patient after COVID-19 infection: a case report. J Med Case Rep. 2021 Feb 19; 15(1):90.